Application of 3D iGuide system for radiofrequency ablation induced by Dyna computed tomography in hepatocellular carcinoma

doi:10.3877/cma.j.issn.2095-5782.2018.02.005

Abstract

Abstract:

Objective:

To evaluate the feasibility and safety of the 3D iGuide system for radiofrequency ablation (RFA) induced by Dyna computed tomography (DynaCT) in the treatment of hepatocellular carcinoma.

Methods:

Nineteen patients with hepatocellular carcinoma undergoing TACE treatment in PLA General Hospital from September to December 2016 were examined by DynaCT scanning with 3D iGuide technique to guide RFA and were evaluated using success rate, intraoperative and postoperative complications, and local treatment effect.

Results:

The success rate of the technique was 100%, and the intraoperative and postoperative complication was mainly pain. There was no serious complication. After one month of the operation, the imaging findings were evaluated including complete remission (CR) of 17 cases and partial remission (PR) of 2 cases.

Conclusions:

3D iGuide puncture technology is safe, effective and easy to treat patients with large hepatocellular carcinoma in DynaCT guiding RFA, which is highly feasible and provides a new guidance for RFA treatment of hepatocellular carcinoma.

Key words: Hepatocellular carcinoma, Radiofrequency ablation, DynaCT, 3D iGuide puncture

Hongjun Yuan, Fengyong Liu, Xin Li, Yang Guan, Maoqiang Wang. Application of 3D iGuide system for radiofrequency ablation induced by Dyna computed tomography in hepatocellular carcinoma[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2018, 06(02): 113-117.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2018.02.005

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2018/V06/I02/113

Figures/Tables 5

References 17

[1]	Jaffray DA, Siewerdsen JH. Cone-beam computed tomography with a flat-panel imager: initial performance characterization[J]. Med Phys, 2000, 27(6):1311-1323. doi:10.1118/1.599009.
[2]	Horner K, O'Malley L, Taylor K, et al. Guidelines for clinical use of CBCT: a review[J]. Dentomaxillofac Radiol, 2015, 44(1):20140225. doi:10.1259/dmfr.20140225.
[3]	El-Sayed H, Ramlawi B. The current status of endovascular repair of thoracic aortic aneurysms（TEVAR）[J]. Methodist Debakey Cardiovasc J, 2011, 7(3):15-19.
[4]	郝伟远，虞希祥. C臂CT在肝癌诊断与介入治疗中的应用现状[J].实用放射学杂志，2011，27(5):788-791. doi：10.3969/j.issn.1002-1671.2011.05.037.
[5]	Kato K, Abe H, Ika M, et al. C-arm cone beam computed tomography guidance for radiofrequency ablation in hepatocellular carcinoma[J]. Oncology, 2017, 92(3):142-152. doi:10.1159/000453665.
[6]	Morimoto M, Numata K, Kondo M, et al. C-arm cone beam CT for hepatic tumor ablation under real-time 3D imaging[J]. AJR Am J Roentgenol, 2010, 194(5):W452-454. doi:10.2214/AJR.09.3514.
[7]	Jiao DC, Han XW, Wu G, et al. 3D CACT-assisted radiofrequency ablation following transarterial chemoembolization for hepatocellular carcinoma: early experience[J]. Asian Pac J Cancer Prev, 2015, 16(17):7897-7903. doi: 10.7314/APJCP.2015.16.17.7897.
[8]	Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases[J]. Cancer, 2005, 103(6):1201-1209. doi:10.1002/cncr.20892.
[9]	Widmann G, Schullian P, Bale R. Radiofrequency ablation of hepatocellular carcinoma[J]. Wien Med Wochenschr, 2013, 163(5-6):132-136.
[10]	杨枫，张抒，刘展，等.多电极射频消融治疗大肝癌的近期疗效评价[J].中华消化外科杂志，2002，1(5):362-364.doi:10.3760/cma.j.issn.1673-9752.2002.05.021.
[11]	Lin SM. Ultrasonography-guided radiofrequency ablation in hepatocellular carcinoma: current status and future perspectives[J]. J Med Ultrasound, 2013, 21(1): 9-15. doi: 10.1016/j.jmu.2013.01.010
[12]	武金玉，林淑芝，吴薇，等.超声引导射频消融治疗邻近肝表面的原发性肝癌[J].中华肿瘤杂志，2015，37(12):933-937.doi:10.3760/cma.j.issn.0253-3766.2015.12.012.
[13]	Lee LH, Hwang JI, Cheng YC, et al. Comparable outcomes of ultrasound versus computed tomography in the guidance of radiofrequency ablation for hepatocellular carcinoma[J]. PLoS One, 2017, 12(1): e0169655. doi: 10.1371/journal.pone.0169655.
[14]	Yang W, Chen MH. Treatment strategy and efficacy of imaging-guided radiofrequency ablation in large hepatocellular carcinoma[J]. Journal of Microwave Surgery, 2009, 27: 27-32. doi: 10.3380/jmicrowavesurg.27.27.
[15]	Livraghi T, Goldberg S N, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions[J]. Radiology, 2000, 214(3):761-768. doi:10.1148/radiology.214.3.r00mr02761.
[16]	Heran NS, Song JK, Namba K, et al. The utility of DynaCT in neuroendovascular procedures[J]. AJNR Am J Neuroradiol, 2006, 27(2):330-332.
[17]	陈文会，江旭，杨继金，等. CT引导介入操作中患者有效辐射剂量的研究[J].介入放射学杂志，2012，21(7): 570-573.doi: 10.3969/j.issn.1008-794X.2012.07.010.

Please choose a citation manager

Content to export